• 検索結果がありません。

資源開発研究部門 Medicinal Resources

N/A
N/A
Protected

Academic year: 2021

シェア "資源開発研究部門 Medicinal Resources"

Copied!
3
0
0

読み込み中.... (全文を見る)

全文

(1)

資源開発研究部門

Medicinal Resources 薬物代謝工学分野 Metabolic Engineering

教 授 服部 征雄 Masao Hattori 准教授 馬 超美 Chao-Mei Ma 助 教(前)鄭 美和 Mi-Hwa Chung 助 教 湯 俊 Jun Tang

◆ 原 著

1) Phuong D.T., Ma C., Hattori M., and Jin J.S.: Inhibitory effects of antrodins A-E from Antrodia cinnamomea and their metabolites on hepatitis C virus protease. Phytother. Res., 23: 582-584, 2009.

2) Sato N.*, Ma C., Komatsu K., and Hattori M.: Triterpene-farnesyl hydroquinone conjugates from Ganoderma sinense. J. Nat.

Prod., 72: 958-961, 2009.

3) Wei Y., Ma C., and Hattori M.: Synthesis of dammarane-type triterpene derivatives and their ability to inhibit HIV and HCV proteases. Bioorg. Med. Chem., 17: 3003-3010, 2009.

4) Ma C., Wei Y., Wang Z., and Hattori M.: Triterpenes from Cynomorium songaricium-analysis of HCV protease inhibitory activity, quantification, and content change under the influence of heating. J. Nat. Med., 63: 9-14, 2009.

5) Yu J., Ma C., Long C., Wang X., Shang M., Cai S., Hattori M., and Namba T.: A new aristololactam from Asarum maximum. J.

Chin. Pharm. Sci., 18: 183-185, 2009.

6) El-Mekkawy S., Abdel-Sattar E., Hattori M., Kawahata T., and Otake T.: Screening of medicinal plants in Egypt for anti-human immunodeficiency virus type-1 (HIV-1) activity. JASMR, 4: 1-8, 2009.

7) Wei Y., Ma C., and Hattori M.: Synthesis and evaluation of A-seco type triterpenoids for anti-HIV-1 protease activity. Eur. J.

Med. Chem., 44: 4112-4120, 2009.

8) Jin J.S., and Hattori M.: Further studies on a human intestinal bacterium Ruminococcus sp. END-1 for transformation of plant lignans to mammalian lignans. J. Agric. Food Chem., 57: 7537-7542, 2009.

9) Ma L., Yang X.W., Cai B.C., and Hattori M.: Intestinal permeability of antitumor alkaloids from the processed seeds of Strychinos nux-vomica in a caco-2 cell model. Planta Med., 75: 631-634, 2009.

10) Wei Y., Ma C., and Hattori M.: Anti-HIV protease triterpenoids from the acid hydrolysate of Panax ginseng. Phytochem. Lett., 2: 63-66, 2009.

11) Zhang Q., Zuo F., Nakamura N., Ma C., and Hattori M.: Metabolism and pharmacokinetics in rats of ganoderiol F, a highly cytotoxic and antitumor triterpene from Ganoderma lucidum. J. Nat. Med., 63: 304-310, 2009.

12) Sato N.*, Zhang Q., Ma C., and Hattori M.: Anti-human immunodeficiency virus-1 protease activity of new lanostane-type triterpenoids from Ganoderma sinense. Chem. Pharm. Bull., 57: 1076-1080, 2009.

13) El Dine R.S., El Halawany A.M., Ma C., and Hattori M.: Inhibition of the dimerization and active site of HIV-1 protease by secondary metabolites from the Vietnamese mushroom Ganoderma colossum. J. Nat. Prod., 72: 2019-2023, 2009.

14) Sasivimolphan P., Lipipun V., Likhitwitayawuid K., Takemoto M., Pramyothin P., Hattori M., and Shiraki K.: Inhibitory activity of oxyresveratrol on wild-type and drug-resistant varicella-zoster virus replication in vitro. Antiviral Res., 84: 95-97, 2009.

◆ 学会報告

1) Hattori M.: Survey of anti-HIV/HCV agents among medicinal mushrooms. NRCT-JSPS Core University Program on Natural Medicine in Pharmaceutical Sciences, The 8th Joint Seminar, Innovative Research in Natural Products for Sustainable Development. 2009, 2, 3-4, Bangkok, Thailand. (Invited lecture)

2) Chung M.H.: Estrogenic effects of Tokishakuyakusan (Japanese traditional medicine) and differences between Tokishakuyakusan and 17β-estradiol. NRCT-JSPS Core University Program on Natural Medicine in Pharmaceutical Sciences,

(2)

The 8th Joint Seminar, Innovative Research in Natural Products for Sustainable Development, 2009, 2, 3-4, Bangkok, Thailand.

3) Sato N.: Isolation of lanostane type triterpenes from Ganoderma sinense and their anti-protease activity from HIV. NRCT-JSPS Core University Program on Natural Medicine in Pharmaceutical Sciences, The 8th Joint Seminar, Innovative Research in Natural Products for Sustainable Development. 2009, 2, 3-4, Bangkok, Thailand.

4) Hattori M., El Dine R.S., Ma C., and Sato N.: Inhibitory substances from medicinal mushrooms: Ganoderma species against HIV-1 protease. The 50th Annual Meeting of the American Society of Pharmacognosy, 2009, 6, 27- 7, 1, Honolulu, Hawaii.

5) Kitalong C., El-Halawany A.M., Ma C., and Hattori M.: A new benzophenone rhamnoside from Phaleria nisidai with estrogenic activity. The 50th Annual Meeting of the American Society of Pharmacognosy, 2009, 6, 27-7, 1, Honolulu, Hawaii.

6) Furuhashi K.*, Chung M., and Hattori M.: Effect of Tokishakuyakusan on ovary and hypothalamus Kiss-1 mRNA expression in hypophsectomized rats. The 50th Annual Meeting of the American Society of Pharmacognosy, 2009, 6, 27-7, 1, Honolulu, Hawaii.

7) Mizuno M.*, Chung M., Ma C., and Hattori M.: Metabolism and disposition of antrodin D in rats. The 50th Annual Meeting of the American Society of Pharmacognosy, 2009, 6, 27- 7, 1, Honolulu, Hawaii.

8) 鄭 美和,伊藤絵理,服部征雄:当帰芍薬散のdendritic spine回復に対する効果について.日本薬学会第129年会,

2009, 3, 26-28, 京都.

9) 王 偉*,馬 超美,服部征雄:ラットにおけるRhynchophyllineA/D/M/E.日本薬学会第129年会,2009, 3, 26-28, 京都.

10) 水野めぐみ*,鄭 美和,陳 琮湜,馬 超美,服部征雄:樟芝菌糸体成分Antrodin Dのラットにおける体内動態.

日本薬学会第129年会,2009, 3, 26-28, 京都.

11) 馬 超美,阿倍 剛,小宮山忠純,服部征雄,Mohsen Daneshtalab:カフェー酸及びキナ酸誘導体の合成と真菌1,3- グルカン合成酵素に対する阻害活性の比較.日本薬学会第129年会,2009, 3, 26-28, 京都.

12) 高田弘弥,萩原由季子,岸 香苗,松本正巳,五十嵐久幸,服部征雄:霊芝エキス抽出法の改良とその機能性評価.

日本薬学会第129年会,2009, 3, 26-28, 京都.

13) 宅江孝修,馬 超美,服部征雄:甘草の新たな腸管収縮抑制成分の探索.第26回和漢医薬学会学術大会,2009, 8, 29-30, 千葉.

14) 王 偉*,馬 超美,服部征雄:Hydroxylation of Rhynchophylline Followed by Glucuronidation with Rat Liver Microsomes 26回和漢医薬学会学術大会,2009, 8, 29-30, 千葉.

15) 古橋慶子*,鄭 美和,服部征雄:多嚢胞性卵巣症候群(PCOS)モデルラットに対する当帰芍薬散の効果.第26 和漢医薬学会学術大会,2009, 8, 29-30, 千葉.

16) El Halawany A.M., El Dine R.S., Ma C., and Hattori M.: Design and Semi-synthesis of HCV NS3/4A Protease Inhibitors Based on Antrodin B Nucleus. 日本生薬学会第56回年会,2009, 10, 3-4, 京都.

17) 馬 紅,鄭 美和,呂 華,服部征雄:春至カプセルの生殖内分泌学的効果と作用メカニズム‐第2報‐.日本生 薬学会第56回年会,2009, 10, 3-4, 京都.

18) 光田聖庸*,水野めぐみ,馬 超美,岩佐衣子,服部征雄:黄連エキスの LC/NMR とラットにおける体内動態.日 本薬学会北陸支部平成21年度第2回総会及び第121回例会,2009, 12, 6, 富山.

◆ その他

1) 馬 超美:Caffeoylquinic acids: Natural occurrence, derivative synthesis and bioactivity. ハワイ大学薬学部のセミナーに 参加,研究発表.2009, 1, 27-28, ヒロ,ハワイ島.

2) 服部征雄:Development of anti HIV and anti HCV agents from natural resources. 桂林医科大学訪問,講演.2009 ,4, 20-27, 桂林,中国.

3) 服部征雄:生薬成分の化学‐ヒト腸内細菌による漢方薬成分の代謝活性化‐.平成21年度漢方薬・生薬研修会,2009,

7, 26, 慶応大学薬学部.

4) 服部征雄:樟芝研究の打合せ.2009, 9, 18-22, 台湾.

5) 服部征雄:Metabolic activation of natural medicines by human intestinal bacteria. 上海交通大学訪問,講演.2009, 9, 27-10, 1, 上海,中国.

6) 服部征雄:東洋人の知恵.富山大学医学薬学祭09特別講演会,2009, 10, 31, 富山.

7) 服部征雄:Antiviral substances from medicinal mushrooms. 大邱カトリック大学にて講演.2009, 11, 18-21, 大邱,韓国.

8) 服部征雄:Development of anti HIV and anti HCV agents from natural resources. アシュート大学,ジャーマン大学にお

(3)

いて講演.2009, 12, 16-28, エジプト.

9) 服部征雄:Metabolic activation of natural medicines by human intestinal bacteria. ミネア大学,カイロ大学において講演.

2009, 12, 16-28, エジプト.

参照

関連したドキュメント

Changes in the Designated Security Plan Article 5 If the owner of the designated Japanese vessel certified as set forth under paragraph 1 of the preceding Article hereinafter

FPSO

瀬戸内千代:第 章第 節、コラム 、コラム 、第 部編集、第 部編集 海洋ジャーナリスト. 柳谷 牧子:第

In case of any differences between the English and Japanese version, the English version shall

In case of any differences between the English and Japanese version, the English version shall

In case of any differences between the English and Japanese version, the English version shall

In case of any differences between the English and Japanese version, the English version shall

In case of any differences between the English and Japanese version, the English version shall